Skip to main content

8 Result(s)

within Cancer Research Remove this filter Makoto Suzuki Remove this filter

and

  1. Article

    Open Access

    Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study

    For chronic pain after thoracic surgery, optimal timing of its diagnosis and effective treatment remains unresolved, although several treatment options are currently available. We examined the efficacy and saf...

    Takuro Miyazaki, Keitaro Matsumoto, Toshihiko Sato, Isao Sano… in BMC Cancer (2024)

    Download PDF (1405 KB) View Article

  2. Article

    Open Access

    A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

    Mixed lineage leukemia 1-rearranged (MLL1-r) acute leukemia patients respond poorly to currently available treatments and there is a need to develop more effective therapies directly disrupting the Menin‒MLL1 com...

    Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi… in Cancer Cell International (2023)

    Download PDF (4641 KB) View Article

  3. Article

    The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma

    Programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) are target molecules for immunotherapy in non-small cell lung cancer. PD-L1 is expressed not only in cancer cells, but also on macrophages, and has been...

    Yusuke Shinchi, Shiho Ishizuka, Yoshihiro Komohara… in Cancer Immunology, Immunotherapy (2022)

    Download PDF (2409 KB) View Article

  4. Article

    Open Access

    A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

    Lymphovascular invasion (LVI), which includes vascular or lymphatic invasions, is a representative prognostic factor even in patients with resected stage IA non-small cell lung cancer (NSCLC). Because tegafur-...

    Tomoshi Tsuchiya, Ryotaro Kamohara, Masashi Muraoka, Takeshi Nagayasu… in BMC Cancer (2020)

    Download PDF (504 KB) View Article

  5. Article

    Open Access

    Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma

    N-methyl-D-aspartate receptors (NMDAR) act as tumor suppressors of digestive malignancies. The expression and genetic methylation patterns of NMDAR2B in non-small cell lung cancer (NSCLC) are unknown.

    Hajime Tamura, Makoto Suzuki, Yasumitsu Moriya, Hidehisa Hoshino… in BMC Cancer (2011)

    Download PDF (1397 KB) View Article

  6. Article

    Open Access

    Spontaneous regression of bone metastasis from renal cell carcinoma; A case report

    Spontaneous regression of metastatic renal cell carcinoma is rarely observed.

    Takahiro Nakajima, Makoto Suzuki, Soichiro Ando, Tomohiko Iida, Akinobu Araki… in BMC Cancer (2006)

    Download PDF (2525 KB) View Article

  7. No Access

    Article

    Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

    Interleukin 6 (IL-6) facilitates the differentiation of B cells to immunoglobulin-secreting cells and is reported to be a proliferative factor in some tumors. In this study, we examined IL-6 production in non-...

    Haruko Yamaji, Toshihiko Iizasa, Eitetsu Koh… in Cancer Immunology, Immunotherapy (2004)

  8. No Access

    Article

    A new pseudo-peptide of Arg-Gly-Asp (RGD) with inhibitory effect on tumor metastasis and enzymatic degradation of extracellular matrix

    A series of pseudo-peptide analogs of the Arg-Gly-Asp (RGD) sequence of fibronectin have been synthe-sized, and their anti-metastatic effects in mice and inhibitory effects on tumor cell invasion in vitro have...

    Hideki Fujii, Naoyuki Nishikawa, Hiroyuki Komazawa… in Clinical & Experimental Metastasis (1998)